Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells

被引:56
作者
MacAulay, K
Blair, AS
Hajduch, E
Terashima, T
Baba, O
Sutherland, C
Hundal, HS
机构
[1] Univ Dundee, Fac Life Sci, Sch Life Sci, Inst Med Sci,Div Mol Physiol, Dundee, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland
[3] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138549, Japan
关键词
D O I
10.1074/jbc.M411648200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of inhibition or constitutive activation of glycogen synthase kinase-3 (GSK3) on glycogen synthase (GS) activity, abundance, and glycogen deposition in L6 rat skeletal muscle cells were investigated. GS protein expression increased similar to5-fold during differentiation of L6 cells (comparing cells at the end of day 5 with those at the beginning of day 3). However, exposure of undifferentiated myoblasts (day 3) to 50 muM SB-415286, a GSK3 inhibitor, led to a significant elevation in GS protein that was not accompanied by changes in the abundance of GLUT4, another late differentiation marker. In contrast, stable expression of a constitutively active form of GSK3beta (GSK3(S9A)) led to a significant reduction (similar to80%) in GS protein that was antagonized by SB-415286. Inhibition of GSK3 or expression of the constitutively active GSK3S9A did not result in any detectable changes in GS mRNA abundance. However, the increase in GS protein in undifferentiated myoblasts or that seen following incubation of cells expressing GSK3S9A with GSK3 inhibitors was blocked by cycloheximide suggesting that GSK3 influences GS abundance possibly via control of mRNA translation. Consistent with the reduction in GS protein, cells expressing GSK3S9A were severely glycogen depleted as judged using a specific glycogen-staining antibody. Inhibiting GSK3 in wild-type or GSK3(S9A)-expressing cells using SB-415286 resulted in an attendant activation of GS, but not that of glucose transport. However, GS activation alone was insufficient for stimulating glycogen deposition. Only when muscle cells were incubated simultaneously with insulin and SB-415286 or with lithium (which stimulates GS and glucose transport) was an increase in glycogen accretion observed. Our findings suggest that GSK3 activity is an important determinant of GS protein expression and that while glycogen deposition in muscle cells is inherently dependent upon the activity/expression of GS, glucose transport is a key rate-determining step in this process.
引用
收藏
页码:9509 / 9518
页数:10
相关论文
共 40 条
  • [1] Control of glycogen synthesis is shared between glucose transport and glycogen synthase in skeletal muscle fibers
    Azpiazu, I
    Manchester, J
    Skurat, AV
    Roach, PJ
    Lawrence, JC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 278 (02): : E234 - E243
  • [2] BEGUINOT F, 1985, J BIOL CHEM, V260, P5892
  • [3] Behrens J, 2000, ANN NY ACAD SCI, V910, P21
  • [4] Coghlan M.P., 2000, CHEM BIOL, V24, P1
  • [5] The renaissance of GSK3
    Cohen, P
    Frame, S
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) : 769 - 776
  • [6] Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment
    Cohen, Y
    Chetrit, A
    Cohen, Y
    Sirota, P
    Modan, B
    [J]. MEDICAL ONCOLOGY, 1998, 15 (01) : 32 - 36
  • [7] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B
    CROSS, DAE
    ALESSI, DR
    COHEN, P
    ANDJELKOVICH, M
    HEMMINGS, BA
    [J]. NATURE, 1995, 378 (6559) : 785 - 789
  • [8] Glycogen synthase kinase 3β regulates cyclin D1 proteolysis and subcellular localization
    Diehl, JA
    Cheng, MG
    Roussel, MF
    Sherr, CJ
    [J]. GENES & DEVELOPMENT, 1998, 12 (22) : 3499 - 3511
  • [9] GSK-3: tricks of the trade for a multi-tasking kinase
    Doble, BW
    Woodgett, JR
    [J]. JOURNAL OF CELL SCIENCE, 2003, 116 (07) : 1175 - 1186
  • [10] Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice
    Eldar-Finkelman, H
    Schreyer, SA
    Shinohara, MM
    LeBoeuf, RC
    Krebs, EG
    [J]. DIABETES, 1999, 48 (08) : 1662 - 1666